SEMAX 10MG
SEMAX, a synthetic analog of the endogenous peptide somatostatin, is presented in a 10-microgram vial as part of scientific investigations into its potential biological interactions. This product is intended exclusively for academic and industrial research applications and is not designed for therapeutic, diagnostic, or other non-research uses.
Research Context
SEMAX is a potent and selective inhibitor of somatostatin receptors, particularly SST1–5. Its development stems from studies exploring the pharmacological modulation of hormone secretion, receptor signaling, and physiological feedback mechanisms in biological systems. Given its structural and functional resemblance to somatostatin, SEMAX has been utilized in preclinical models to dissect the role of somatostatin signaling in endocrine homeostasis, neuroendocrine regulation, and pathological conditions where receptor blockade may be relevant.
Research Overview
SEMAX’s primary utility lies in its ability to block somatostatin-mediated feedback loops, making it a valuable tool for researchers investigating:
- Gastrointestinal physiology, including pancreatic and intestinal hormone secretion
- Neuroendocrine signaling and stress-response pathways
- Neoplastic processes where somatostatin receptor expression is elevated
- Developmental and regenerative studies in animal models
While its mechanism of action is well-characterized in vitro and in small animal studies, its effects on larger systems or complex biological processes remain the subject of ongoing investigation. Researchers should conduct experiments in compliance with institutional guidelines and ethical standards governing peptide synthesis and biological testing.
Key Research Focus Areas
| Area of Study | Potential Applications |
|---|---|
| Endocrine function modulation | Investigation of SEMAX’s role in modulating pituitary-hypothalamic interactions, including growth hormone suppression and thyroid hormone regulation. |
| Gastrointestinal pharmacology | Assessment of its impact on gastric acid secretion, nutrient absorption, and enteroendocrine cell function in animal models. |
| Neuroendocrine research | Exploration of its effects on dopamine, serotonin, and corticotropin-releasing factor signaling in stress and addiction models. |
| Oncological studies | Evaluation of SEMAX as a probe for somatostatin receptor expression in tumor cell lines and xenograft models. |
Due to its pharmacological potency and specific binding affinity, SEMAX is typically employed at concentrations ranging from nanomolar to micromolar in research settings. Proper handling, storage, and disposal protocols are recommended as outlined in laboratory safety manuals.
Important Safety and Compliance Notice
This product is intended solely for academic, industrial, or research purposes and is not authorized for use in human or animal therapeutics, diagnostics, or consumer applications. SEMAX may exhibit systemic effects in experimental animals and should be administered under the supervision of qualified personnel trained in peptide pharmacology and biosafety protocols. Researchers must comply with all applicable regulatory requirements, including but not limited to those specified in the Research Chemicals Act (RCA) or equivalent legislation in their jurisdiction.
For research use only. Not for human or animal consumption.
Reviews
There are no reviews yet.